These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12686012)

  • 1. Current Treatment Options in Raynaud's Phenomenon.
    Generini S; Del Rosso A; Pignone A; Matucci Cerinic M
    Curr Treat Options Cardiovasc Med; 2003 Apr; 5(2):147-161. PubMed ID: 12686012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
    Linnemann B; Erbe M
    Vasa; 2016; 45(3):201-12. PubMed ID: 27129065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Part II: The treatment of primary and secondary Raynaud's phenomenon.
    Curtiss P; Svigos K; Schwager Z; Lo Sicco K; Franks AG
    J Am Acad Dermatol; 2024 Feb; 90(2):237-248. PubMed ID: 35809802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
    Anderson JE; Held N; Wright K
    Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system mediators and Raynaud's phenomenon.
    Wood HM; Ernst ME
    Ann Pharmacother; 2006 Nov; 40(11):1998-2002. PubMed ID: 17003081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raynaud's Phenomenon: Reviewing the Pathophysiology and Management Strategies.
    Nawaz I; Nawaz Y; Nawaz E; Manan MR; Mahmood A
    Cureus; 2022 Jan; 14(1):e21681. PubMed ID: 35242466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Severe Raynaud's Phenomenon.
    Wigley FM
    J Clin Rheumatol; 1996 Apr; 2(2):103-11. PubMed ID: 19078039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of Raynaud's phenomenon.
    Belch JJ; Ho M
    Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.
    Thompson AE; Shea B; Welch V; Fenlon D; Pope JE
    Arthritis Rheum; 2001 Aug; 44(8):1841-7. PubMed ID: 11508437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Controlled Trial of Acupressure for the Treatment of Raynaud's Phenomenon: The difficulty of conducting a trial in Raynaud's phenomenon.
    Gladue H; Berrocal V; Harris R; Tsou PS; Edhayan G; Ohara R; Khanna D
    J Scleroderma Relat Disord; 2016; 1(2):226-233. PubMed ID: 27840853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis and treatment of Raynaud's phenomenon: a practical approach.
    Pope JE
    Drugs; 2007; 67(4):517-25. PubMed ID: 17352512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Office evaluation and treatment of Raynaud's phenomenon.
    Bolster MB; Maricq HR; Leff RL
    Cleve Clin J Med; 1995; 62(1):51-61. PubMed ID: 7859402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The therapy of Raynaud's phenomenon].
    Di Giacinto G
    Clin Ter; 1993 Feb; 142(2):161-74. PubMed ID: 8472530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's Phenomenon.
    Coffman JD
    Curr Treat Options Cardiovasc Med; 2000 Jun; 2(3):219-226. PubMed ID: 11096527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of thoracic outlet syndrome on the epidemiology and clinical presentation of apparently primary Raynaud's phenomenon. A prospective study in 570 patients.
    Pistorius MA; Planchon B
    Int Angiol; 1995 Mar; 14(1):60-4. PubMed ID: 7658106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon.
    Curtiss P; Schwager Z; Cobos G; Lo Sicco K; Franks AG
    J Am Acad Dermatol; 2018 Jun; 78(6):1110-1118.e3. PubMed ID: 29408338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.